7
Participants
Start Date
May 31, 2003
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
Weekly procrit dosing
The dose is standard of care, the investigational piece is the dosing schedule itself. Either weekly or Interval-dosing schedule subjects will get the study drug once every week until hematocrit is greater than 36% or Hemoglobin reaches a value of 12 g/dl, then they will get study drug once every other week.
Interval Dosing
The dosing of Procrit is standard of care, it is the schedule that is the investigational piece.
OHSU Knight Cancer Institute, Portland
Collaborators (1)
Ortho Biotech, Inc.
INDUSTRY
OHSU Knight Cancer Institute
OTHER